Nordic delegation to attend Swiss Biotech Day 2025 for the first time

For the first time, a joint Nordic delegation will participate in Swiss Biotech Day 2025, taking place on May 5–6 in Basel, Switzerland.

The initiative brings together innovative companies from across the Nordic region to showcase the strength and diversity of the Nordic life science ecosystem on an international stage. The participating companies include:

  • Cellectricon – Specializing in neurobiology drug discovery with groundbreaking in vitro concepts.
  • Cytel – Supporting life sciences companies with advanced analytics and strategies.
  • Invest in Skåne – Representing a strong R&D hub with focus areas including oncology, inflammation, neuroscience, and ATMP.
  • Mavatar – Offering data-driven precision medicine solutions across disease areas.
  • Pelago Bioscience – Experts in cellular target engagement using CETSA® technology to boost confidence early in drug discovery.
  • SmiLe Venture Hub – A leading incubator helping life science startups grow from idea to market.
  • VentriLabs – Providing a gentle, shear-free liquid flow technology that protects sensitive biological samples in biotech and medtech applications.

The delegation is organized in collaboration between SwedenBIO, The Life Science Cluster, and Medicon Valley Alliance.

Swiss Biotech Day is one of Europe’s leading biotechnology conferences, attracting professionals from across the global life science industry.